MedTrace Logo

Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment

NCT03791216 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2025-07-29

No results posted yet for this study

Summary

This study will assess differences in inflammatory proteins, lipoprotein composition, cholesterol efflux and HDL-proteome in moderate-to-severe pediatric psoriasis who at baseline begin systemically administered therapy vs: a) healthy controls; and b) patients with milder psoriasis.

Conditions

Interventions

OTHER

Fasting blood draw for lipid assessments

Fasting blood draw for lipid assessments

Sponsors & Collaborators

Principal Investigators

  • Amy Paller, MD · Northwestern University

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2025-06-18
Completion
2025-06-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03791216 on ClinicalTrials.gov